Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Renee Burr"'
Publikováno v:
Clinical Nephrology. 86:141-146
BACKGROUND Data on hemodialysis (HD)-related organism specific bacteremia rates by type of access over an extended period are scant in the literature. Using a registry data base we examined all positive blood cultures by organisms for each type of HD
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 35:98-101
Publikováno v:
Hemodialysis International. 7:73-104
Vascular access care accounts for a third of ESRD cost and is a leading cause of morbidity in hemodialysis (HD) patients. We designed this study to identify the risk factors for vascular access infection and to determine the cost of related hospitali
Publikováno v:
Kidney International. 54(2):518-524
Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Background Acute renal failure (ARF) is traditionally considered a poor prognostic factor in end-stage liver disease and is associated with a morta
Autor:
Rachel G. Miller, Sophie Lee, Judith Bernardini, Renee Burr, Michele Shields, Heena Sheth, Emanuel N. Vergis, Beth Piraino
Publikováno v:
Infection control and hospital epidemiology. 31(1)
We examined the Clostridium difficile infection rate and risk factors in an outpatient dialysis cohort. The Cox proportional hazard for developing C. difficile infection was significantly higher with high comorbidity index and low serum albumin level
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 1(6)
The impact of dialysis modality on infection, especially early in the course of dialysis, has not been well studied. This study compared infection between hemodialysis (HD) and peritoneal dialysis (PD) from the start of dialysis and evaluated factors
Autor:
Ameer Ali, Kelli Logue, Renee Burr, Kevin Ho, Joan Marszalek, Susan Martin, Pat Seddon, Stacy Andersen, Yuefang Chang
Publikováno v:
American Journal of Kidney Diseases. 57:B21
Publikováno v:
American Journal of Kidney Diseases. 57:B93
Autor:
James B. Lohr, Mike R. Sather, Harold M. Szerlip, K. Smirnakis, A. Felsenfeld, C. Bethea, J. White, J. Walczyk, K. Borovitz, G. Rodriguez-Vega, D. Govan, M. Gropper, J. Penfield, Stuart R. Warren, Gabriel Contreras, Kirsten L. Johansen, M. Arcia, Ravi Thadhani, Jeffrey A. Kraut, Renee Burr, S. Rodriguez, G. D. Huang, J. Diego, Kathleen M. Swanson, Paul J. Scheel, George Feldman, Massimo Antonelli, C. McCarthy, A. Raine, Mark Unruh, P. Rogers, E. Grum, M. Shields, J. Amanzadeh, M. Castro, S. Cohn, J. Thornton, E. Deterding, Kenneth Edward Graves, Mary Brophy, Ihab M. Wahba, Steven D. Weisbord, K. Belanger, Emil P. Paganini, H. Sterling, Joseph N. Vitale, A. Sajgure, C. Rosado-Rodriguez, A. Alper, B. Vaghaiwalla, Andrew A. Quartin, D. McBride, L. Mandich, Robert A. Star, M. Jagadeesan, C. Cely, Nabeel Aslam, P. Fall, J. Aubrecht, D. Cloen, Paul W. Eggers, L. Yohe, Joseph O. Moore, E. Satter, G. Nagami, Janet Wittes, M. Perkal, M. Choi, M. Pescatore, M. Garcia, Francis B. Gabbai, E. Jaimes, J. Russo, D. Humphries, M. Jaradat, B. Leeman, B. Levine, A. Swann, M. Krause, J. Dingsdale, Peter Peduzzi, S. Woods, T. Bland, L. Sweeney, S. Michler, William D Paulson, N. Sickafoose, W. Rodriguez, I. Espinal, Q. Li, C. Dalzell, E. Simon, Glenn M. Chertow, Aldo J. Peixoto, N. Gourley, A. Hurtado, R. Smith, Daniel H. Kett, J. Samuels, Devasmita Choudhury, A. Galera, K. Liu, C. M. Haakenson, J. Marszalek, Hamid Rabb, P. Overberger, T. Seifert, Timothy J. O'Leary, G. Tasby, S. Mullaney, John L. Niles, James T. McCarthy, Kevin W. Finkel, V. McBride, M. Shaver, Shahriar Moossavi, Ann M. O’Hare, Susan T. Crowley, N. Ricci, K. Morris, B. Young, D. Wassel, J. Foringer, C. Joncas, Jane Hongyuan Zhang, G. Galvin, C. Vilchez, R. Fissel, Michael V. Rocco, K. Dellert, Taposh Roy, E. Heck, A. Kossack, M. Kollef, A. Shaw, Mohamed G. Atta, C. Geffel, Dennis L. Andress, R. Franchini, Mark W. Smith, G. G. Koch, Roy G. Brower, Alfred F. Connors, Suzanne Watnick, Robert L. Bacallao, C. Carvalho, H. Rahman, S. Schmid, P. Oyuela, C. de la Cuesta, G. Viol, M.C. Ramkumar, Joseph A. Eustace, M. Hussain, Harold I. Feldman, R. Horney, P. Su, D. Carvalho, John B. Stokes, Sevag Demirjian, Joel W. Greer, H. Totten, Darren J. Kelly, C. Fye, B. Taylor Thompson, V. Ramanathan, Michael P. Donahoe, B. Efron, G. Dolson, H. Bazari, M. Koenigsberg, R. Katneni, E. Young, John R. Feussner, Vecihi Batuman, J. Duffney, Thomas E. Stewart, Anitha Vijayan, A. Lindner, David H. Lovett, L. Durant, Theresa Z. O'Connor, M. Hoffman, Roland M. H. Schein, E. Hammer, D. Steele, P. Arora, M. Halverson, W. Fissel, S. O'Neil, Paul M. Palevsky, M. Alam, C. Kulivan, Andrew M. Siroka, A. Dreisbach, K. Cho, J. Yared, K. Sambandam, Laura L Mulloy, A. Mogyorosi, D. H. Krueger, A. Barchi-Chung, R. Brienza, Michael A. Matthay, R. Venkataraman, John A. Kellum, K. Laliberte, Uptal D. Patel
Publikováno v:
New England Journal of Medicine. 361:2391-2391
We randomly assigned critically ill patients with acute kidney injury and failure of at least one nonrenal organ or sepsis to receive intensive or less intensive renal-replacement therapy. The primary end point was death from any cause by day 60. In